Meanwhile, I hardly need to add, the CEO walks off with banker-style bonuses: a golden hello last year of £4m, and to come a 180% performance related annual bonus. So it’s all about him and not about the ostensible purpose of the company: to make the drugs we need.
I thought the news that Astra Zeneca was closing the legendary ex-ICI research facility at Alderley Park was bad enough but now they announce 2,300 more job cuts, UK portion unspecified. And it is refocusing: “It will cut spending on neuroscience and antibiotics”. Antibiotics? Those are the drugs the UK Chief Medical Officer says we separately need revived to cope with drug resistance.
Meanwhile, I hardly need to add, the CEO walks off with banker-style bonuses: a golden hello last year of £4m, and to come a 180% performance related annual bonus. So it’s all about him and not about the ostensible purpose of the company: to make the drugs we need. Comments are closed.
|
AuthorI'm a writer whose interests include the biological revolution happening now, the relationship between art and science, jazz, and the state of the planet Archives
March 2016
Categories
All
|